Literature DB >> 8078142

Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy.

J H Gurwitz1, J Avorn, R L Bohn, R J Glynn, M Monane, H Mogun.   

Abstract

OBJECTIVE: To determine whether there is an increased risk for the initiation of antihypertensive therapy in older persons prescribed nonaspirin, nonsteroidal anti-inflammatory drugs (NSAIDs).
DESIGN: Case-control study.
SETTING: New Jersey Medicaid program. PATIENTS: Medicaid enrollees aged 65 years and older. The 9411 case patients were newly started on an antihypertensive medication between November 1981 and February 1990. A similar number of controls were randomly selected among other enrollees. MAIN OUTCOME MEASURES: We used logistic regression to determine the odds ratio for the initiation of antihypertensive therapy in patients using NSAIDs relative to nonusers, after adjusting for age, sex, race, nursing home residence, number of prescriptions filled, intensity of physician utilization, and days hospitalized.
RESULTS: The adjusted odds ratio for the initiation of antihypertensive therapy for recent NSAID users compared with nonusers was 1.66 (95% confidence interval, 1.54 to 1.80). The odds ratio increased with increasing daily NSAID dose: the adjusted odds ratio for users of low average daily doses relative to nonusers was 1.55 (95% CI, 1.38 to 1.74), that for medium-dose users was 1.64 (95% CI, 1.44 to 1.87), and that for high-dose users was 1.82 (95% CI, 1.62 to 2.05).
CONCLUSIONS: Use of NSAIDs may increase the risk for initiation of antihypertensive therapy in older persons. Given the high prevalence of NSAID use by elderly persons, this association may have important public health implications for the management of hypertension in the older population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078142

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  38 in total

1.  Prostate cancer: 12. The economic burden.

Authors:  S A Grover; H Zowall; L Coupal; M D Krahn
Journal:  CMAJ       Date:  1999-03-09       Impact factor: 8.262

2.  Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly.

Authors:  Kathrine F Vandraas; Olav Spigset; Milada Mahic; Lars Slørdal
Journal:  Eur J Clin Pharmacol       Date:  2010-04-20       Impact factor: 2.953

3.  Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly.

Authors:  Til Stürmer; Sebastian Schneeweiss; M Alan Brookhart; Kenneth J Rothman; Jerry Avorn; Robert J Glynn
Journal:  Am J Epidemiol       Date:  2005-05-01       Impact factor: 4.897

4.  Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration.

Authors:  Til Stürmer; Sebastian Schneeweiss; Jerry Avorn; Robert J Glynn
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

Review 5.  Paracetamol: new vistas of an old drug.

Authors:  Alfio Bertolini; Anna Ferrari; Alessandra Ottani; Simona Guerzoni; Raffaella Tacchi; Sheila Leone
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

6.  "Iatrogenicity cascade": doing harm by treating harm?

Authors:  Claudia Christina Wagner; Jerome Biollaz; Markus Zeitlinger; Thierry Buclin
Journal:  Wien Med Wochenschr       Date:  2009

Review 7.  Tolerability of topical NSAIDs in the elderly: do they really convey a safety advantage?

Authors:  J M Evans; T M MacDonald
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

8.  Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.

Authors:  M D Krahn; A Coombs; I G Levy
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

9.  Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.

Authors:  Youfei Guan; Yahua Zhang; Jing Wu; Zhonghua Qi; Guangrui Yang; Dou Dou; Yuansheng Gao; Lihong Chen; Xiaoyan Zhang; Linda S Davis; Mingfeng Wei; Xuefeng Fan; Monica Carmosino; Chuanming Hao; John D Imig; Richard M Breyer; Matthew D Breyer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 10.  Cardiovascular effects of noncardiovascular drugs.

Authors:  Satish R Raj; C Michael Stein; Pablo J Saavedra; Dan M Roden
Journal:  Circulation       Date:  2009-09-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.